Folic Acid for Vascular Outcome Reduction In Transplantation (FAVORIT)
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Andrew Levey, M.D.
Tufts Medical Center
Study Director - Myra A Carpenter, PhD
University of North Carolina, Chapel Hill
Principal Investigator
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
30 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Universidade Federal de Sao Paulo
São Paulo, São Paulo, Brazil
- London Health Sciences Center
London, Ontario, Canada
- Toronto General Hospital
Toronto, Ontario, Canada
- University of Alabama at Birmingham School of Medicine
Birmingham, Alabama, United States
- Banner Good Samaritan Transplant
Phoenix, Arizona, United States
- Cedars-Sinai Health System/center for Kidney Diseases and Transplantation
Los Angeles, California, United States
- University of California at Los Angeles
Los Angeles, California, United States
- University of California at San Francisco
San Francisco, California, United States
- Northwestern University
Chicago, Illinois, United States
- Southern Illinois University
Springfield, Illinois, United States
- Indiana University
Indianapolis, Indiana, United States
- University of Iowa Hospitals and Clinics
Iowa City, Iowa, United States
- Maine Medical Center
Portland, Maine, United States
- University of Maryland Medical Center
Baltimore, Maryland, United States
- Brigham and Women'S Hospital
Boston, Massachusetts, United States
- University of Michigan Medical Center
Ann Arbor, Michigan, United States
- Faireview University Medical Center
Minneapolis, Minnesota, United States
- Hennepin County Medical Center
Minneapolis, Minnesota, United States
- Mayo Clinic
Rochester, Minnesota, United States
- Washington University
St Louis, Missouri, United States
- Albany Medical Center
Albany, New York, United States
- State University of New York Downstate Medical Center
Brooklyn, New York, United States
- Duke University Medical Center
Durham, North Carolina, United States
- East Carolina University
Greenville, North Carolina, United States
- the Ohio State University Medical Center
Columbus, Ohio, United States
- Oregon Health Sciences University
Portland, Oregon, United States
- Drexel University
Philadelphia, Pennsylvania, United States
- Rhode Island Hospital
Providence, Rhode Island, United States
- University of Wisconsin at Madison
Madison, Wisconsin, United States
- Medical College of Wisconsin
Milwaukee, Wisconsin, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 May 2002
- Primary completion
- 31 Oct 2011
- Completion
- 31 Oct 2011
- Last update posted
- 18 Oct 2017
- Registered enrollment
- 4,110
- Registry id
- NCT00064753
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.